# Vitexdoin F (Vitex species-derived flavonoid compound)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/vitexdoin-f-vitex-species-derived-flavonoid-compound
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-04-02
**Evidence Score:** 1 / 10
**Category:** Compound
**Also Known As:** Vitex-derived antioxidant compound, Vitexdoin-F, Vitex negundo flavonoid isolate, Nirgundi phytochemical fraction, Vitexdoin F

## Overview

Vitexdoin F is a flavonoid-class compound derived from Vitex species that exerts antioxidant activity principally through direct [free radical scaveng](/ingredients/condition/antioxidant)ing of DPPH and ABTS radicals, a mechanism shared with co-occurring phenolics such as isoorientin, chlorogenic acid, and vitexin. In comparative in vitro assays, flavonoid fractions from Vitex species have demonstrated DPPH radical scavenging capacity exceeding that of ascorbic acid, though no standardized human clinical dose or confirmed isolated-compound IC50 for Vitexdoin F specifically has been published in peer-reviewed literature as of the current evidence base.

## Health Benefits

- **[Antioxidant Activity](/ingredients/condition/antioxidant)**: Vitexdoin F and co-occurring Vitex flavonoids scavenge DPPH and ABTS free radicals at potency reported to surpass ascorbic acid in head-to-head in vitro assays; this activity correlates strongly with total phenolic content of the fractions in which it is found.
- **Anti-inflammatory Potential**: Vitex genus extracts containing flavonoids structurally related to Vitexdoin F have demonstrated suppression of pro-[inflammatory pathway](/ingredients/condition/inflammation)s in preclinical models, likely through inhibition of cyclooxygenase and modulation of cytokine signaling cascades.
- **Antispasmodic Effects**: Flavonoid fractions from Vitex negundo at concentrations of 0.1–1.0 mg/mL produce concentration-dependent rightward shifts in calcium concentration-response curves, indicating functional calcium channel blockade that reduces smooth muscle contractility.
- **[Antimicrobial](/ingredients/condition/immune-support) Synergy**: Alcoholic leaf extracts enriched in vitexin and quercetin derivatives — compounds co-occurring with Vitexdoin F — have been shown to enhance the potency of antibiotics such as ciprofloxacin, effectively lowering the minimum inhibitory concentration required against resistant bacterial strains.
- **Ferric Ion Reduction (FRAP Activity)**: Phenolic fractions from Vitex species, including those containing Vitexdoin F's chemical class, demonstrate significant ferric reducing antioxidant power, suggesting capacity to chelate and neutralize redox-active metal ions that catalyze oxidative damage.
- **[Neuroprotective](/ingredients/condition/cognitive) Candidate Activity**: Traditional Ayurvedic use of Vitex negundo for headache and nervous system complaints, combined with the known neuroprotective profiles of structurally analogous flavonoids such as isoorientin and scutellarin, positions Vitexdoin F as a candidate for neuroprotective investigation, though direct evidence is absent.
- **Potential Antiproliferative Properties**: Compounds from Vitex leptobotrys have shown inhibitory activity against unspecified biological targets at 5 μM concentrations in preliminary screening, suggesting cytotoxic or antiproliferative potential warranting further mechanistic characterization.

## Mechanism of Action

The primary [antioxidant](/ingredients/condition/antioxidant) mechanism attributed to Vitexdoin F and structurally related Vitex flavonoids involves direct hydrogen atom transfer (HAT) and single electron transfer (SET) to neutralize DPPH, ABTS, and peroxyl radicals, a capacity driven by the catechol or polyhydroxyl arrangement on the flavonoid B-ring that stabilizes the resulting phenoxyl radical through resonance delocalization. Secondary antioxidant mechanisms include ferric ion chelation via the 3-hydroxyl and 4-carbonyl groups characteristic of flavonols, thereby interrupting Fenton-type reactions that generate highly reactive hydroxyl radicals from endogenous iron pools. At the smooth muscle level, flavonoid fractions containing compounds of this class produce rightward shifts in calcium concentration-response curves at 0.1–1.0 mg/mL, consistent with competitive or non-competitive antagonism at L-type voltage-gated calcium channels, reducing intracellular calcium flux and consequent contractile activation. [Antimicrobial](/ingredients/condition/immune-support) synergy with fluoroquinolone antibiotics such as ciprofloxacin is hypothesized to involve inhibition of bacterial efflux pump activity by flavonoid moieties, reducing drug expulsion from resistant bacterial cells and restoring effective intracellular antibiotic concentrations.

## Clinical Summary

There are no published clinical trials — randomized or otherwise — that have evaluated Vitexdoin F as an isolated compound in human subjects; the totality of available clinical-adjacent evidence derives from in vitro cell-free assays and traditional ethnopharmacological records pertaining to Vitex species extracts broadly. Outcome measures that have been assessed preclinically include radical scavenging percentages in DPPH assays (reportedly exceeding ascorbic acid reference controls), minimum inhibitory concentration reductions in antibiotic co-administration models, and calcium-channel blocking concentrations in smooth muscle preparations, but none of these endpoints have been translated into human efficacy or safety data. Effect sizes from in vitro [antioxidant](/ingredients/condition/antioxidant) comparisons are promising at face value but are well recognized in nutritional science to have low predictive validity for in vivo outcomes due to absorption, distribution, [metabolism](/ingredients/condition/weight-management), and excretion barriers. Confidence in any clinical claim for Vitexdoin F specifically must therefore be rated as very low pending isolation, structural characterization, pharmacokinetic profiling, and prospective human investigation.

## Nutritional Profile

Vitexdoin F is a discrete phytochemical compound rather than a whole food or nutritional ingredient, and therefore does not contribute macronutrients, essential micronutrients, or caloric value in any meaningful supplemental context. The Vitex negundo leaf matrix from which it is derived contains a complex mixture of bioactive phytochemicals identified by GC-MS and LC-ECD analysis, including octadecadienoic acid (an omega-6 fatty acid derivative comprising 21.93% of wild leaf extract and up to 47.79% in green callus), flavonoid glycosides including vitexin, isoorientin, cynaroside, and scutellarin, phenolic acids including chlorogenic acid, terpenoids including D-viridiflorol (6.79%), and minor quantities of organic acids such as butyric acid. Bioavailability of flavonoid glycosides from plant matrices is generally moderate and dependent on gut microbiota-mediated deglycosylation to aglycone forms prior to intestinal absorption; quercetin and vitexin aglycones exhibit oral bioavailability in the range of 20–50% in human pharmacokinetic studies, though no specific data for Vitexdoin F exists. The presence of concurrent food matrix lipids may enhance absorption of more hydrophobic flavonoid aglycone forms through micellar solubilization in the small intestine.

## Dosage & Preparation

- **Crude Methanolic Leaf Extract**: Used exclusively in research settings; no standardized supplement dose established; typical laboratory preparations use 80% methanol extraction of dried Vitex negundo leaf material at 1:10 w/v ratios.
- **Alcoholic (Ethanol) Leaf Extract**: Employed in antibiotic synergy studies; research concentrations range from 0.1 to 1.0 mg/mL in vitro; no human equivalent dose has been derived.
- **Callus Culture-Derived Extract**: Micropropagated green and white callus from Vitex negundo (on MS medium supplemented with BAP 2.0 mg/L and 2,4-D 0.2 mg/L) yields elevated octadecadienoic acid and flavonoid content compared to wild-type leaves; proposed as a biotechnological supply pathway but not commercially available.
- **Traditional Ayurvedic Preparation**: Fresh or dried Vitex negundo leaves are prepared as decoctions or poultices for topical [anti-inflammatory](/ingredients/condition/inflammation) use in Indian traditional medicine; oral doses in ethnobotanical records are not standardized to Vitexdoin F content.
- **Standardization Status**: No pharmacopoeial monograph or commercial standardization to Vitexdoin F percentage exists; preparations are not standardized by current supplement industry practices.
- **Timing and Administration**: No evidence-based guidance on dosing timing, fed/fasted state, or administration route for Vitexdoin F specifically; general flavonoid bioavailability literature suggests consumption with dietary fat may enhance absorption of lipophilic aglycone forms.

## Safety & Drug Interactions

The safety profile of Vitexdoin F as an isolated compound has not been evaluated in any published toxicological study, preclinical animal safety assessment, or human clinical investigation, meaning that no established no-observed-adverse-effect level (NOAEL), acceptable daily intake, or maximum safe dose can be cited with scientific rigor. Crude Vitex negundo extracts have been used in traditional medicine for centuries without systematic documentation of acute toxicity, but the detection of chlorpyrifos (an organophosphate pesticide) at 42.98% in one GC-MS fraction of analyzed extracts underscores the importance of rigorous quality control and contaminant screening in any extract-based preparation. Potential drug interactions of clinical significance include enhanced antibacterial activity when co-administered with fluoroquinolone antibiotics such as ciprofloxacin — a synergy that may lower effective antibiotic doses but could also unpredictably alter pharmacokinetics — and theoretical interactions with calcium channel blocker medications given the demonstrated smooth muscle calcium channel antagonism of flavonoid fractions at 0.1–1.0 mg/mL. Pregnancy and lactation safety is entirely unstudied for Vitexdoin F; given the pharmacological activity of Vitex genus extracts and their traditional use in postpartum contexts, use during pregnancy should be avoided until safety data are available, and consultation with a qualified healthcare provider is essential before any supplementation.

## Scientific Research

The evidence base for Vitexdoin F as a discrete, isolated compound is essentially absent from indexed peer-reviewed literature; the compound's properties are currently inferred from studies on crude or semi-purified extracts of Vitex negundo and related species that contain structurally related flavonoids. Available research consists entirely of in vitro investigations including GC-MS and LC-ECD phytochemical profiling, DPPH/ABTS/FRAP/ORAC radical scavenging assays, antibiotic synergy testing, and calcium channel pharmacology experiments — none of which constitute clinical evidence for Vitexdoin F itself. No published randomized controlled trials, cohort studies, or systematic reviews addressing Vitexdoin F by name have been identified, and no validated pharmacokinetic, bioavailability, or dose-response data in humans or animal models exist for this specific compound. The broader Vitex genus literature provides a plausible mechanistic framework, but extrapolating those findings to Vitexdoin F as a singular chemical entity requires considerable caution and explicit acknowledgment of the current data gap.

## Historical & Cultural Context

Vitex negundo, the primary botanical source genus for Vitexdoin F-class compounds, holds a prominent place in Ayurvedic medicine under the Sanskrit name 'Nirgundi,' where the leaves, roots, and seeds have been prescribed for over two millennia for conditions including fever, [inflammation](/ingredients/condition/inflammation), rheumatic pain, headache, and convulsions, as documented in the Charaka Samhita and Sushruta Samhita. In traditional Chinese medicine, related Vitex species including Vitex trifolia (Manjingzi) are used to treat wind-heat conditions, eye disorders, and headache, reflecting a convergent ethnopharmacological recognition of this genus across geographically separate healing traditions. In the Philippines and Southeast Asia, Vitex negundo leaves are prepared as steam inhalations, poultices, and bath preparations for postpartum recovery and musculoskeletal pain, demonstrating the breadth of traditional application forms. The specific compound designation 'Vitexdoin F' likely represents a modern phytochemical isolation effort to characterize individual bioactive constituents from these well-regarded traditional preparations, continuing a scientific tradition of validating Ayurvedic botanical claims through molecular characterization.

## Synergistic Combinations

Vitexdoin F-containing Vitex flavonoid fractions have demonstrated pharmacological synergy with fluoroquinolone antibiotics, particularly ciprofloxacin, where co-administration reduces the minimum inhibitory concentration required against resistant bacterial strains, a mechanism hypothesized to involve flavonoid-mediated efflux pump inhibition restoring intracellular antibiotic accumulation. Within the Vitex leaf extract matrix, the co-presence of chlorogenic acid, isoorientin, and scutellarin creates a multi-mechanism [antioxidant](/ingredients/condition/antioxidant) network combining radical scavenging (flavonoids), metal chelation (catechol-containing phenolics), and singlet oxygen quenching, which may produce additive or synergistic total antioxidant capacity exceeding individual component contributions. In the context of antioxidant supplementation stacks, structurally analogous flavonoids such as quercetin and luteolin are known to exhibit synergistic radical-scavenging interactions with vitamin C (ascorbic acid) through phenoxyl radical regeneration chemistry, suggesting that Vitexdoin F may participate in similar redox recycling partnerships, though this has not been tested directly.

## Frequently Asked Questions

### What is Vitexdoin F and where does it come from?

Vitexdoin F is a bioactive flavonoid-class compound isolated from plants of the Vitex genus, particularly Vitex negundo — a shrub native to South and Southeast Asia used for over two millennia in Ayurvedic medicine under the name Nirgundi. The compound is concentrated in the leaf tissues and is co-present with other phenolics including vitexin, isoorientin, chlorogenic acid, and quercetin derivatives, though its complete structural characterization and isolation as a pure compound has not been widely reported in indexed scientific literature.

### Is Vitexdoin F stronger than vitamin C as an antioxidant?

In DPPH radical scavenging assays conducted on Vitex species flavonoid fractions, antioxidant activity has been reported to exceed that of ascorbic acid (vitamin C) used as a reference standard, which is the basis for Vitexdoin F's classification as a potent antioxidant. However, this comparison is made in cell-free in vitro assays and does not necessarily translate to superior antioxidant efficacy in the human body, where absorption, bioavailability, and metabolic conversion significantly influence functional activity; no head-to-head human clinical comparison exists.

### What are the known health benefits of Vitexdoin F?

Based on preclinical in vitro research on Vitex species extracts, compounds in the Vitexdoin F chemical class have demonstrated antioxidant (DPPH/ABTS/FRAP), anti-inflammatory, antispasmodic (via calcium channel blockade at 0.1–1.0 mg/mL), and antibiotic-synergistic activities. It is critically important to note that no human clinical trials have evaluated Vitexdoin F specifically, so all health benefit claims remain preliminary and are extrapolated from broader Vitex genus phytochemical research rather than direct compound-specific evidence.

### What is the recommended dosage of Vitexdoin F?

No standardized supplemental dose for Vitexdoin F has been established because the compound has not been evaluated in human pharmacokinetic or clinical efficacy studies; current research uses crude methanolic or ethanolic Vitex negundo leaf extracts at laboratory concentrations of 0.1–1.0 mg/mL for in vitro experiments only. Traditional Ayurvedic preparations of Vitex negundo do not specify dosing in terms of Vitexdoin F content, and no commercial supplement standardized to this compound is currently available on the market.

### Is Vitexdoin F safe to take, and does it interact with medications?

The safety of Vitexdoin F as an isolated compound is entirely unstudied in formal toxicology or clinical settings, making it impossible to confirm a safe supplemental dose or rule out adverse effects. Of particular note for drug interactions, Vitex flavonoid fractions have demonstrated synergistic effects with ciprofloxacin and potentially other fluoroquinolone antibiotics, and calcium channel-blocking activity has been observed in vitro at pharmacologically relevant concentrations, suggesting possible interactions with cardiovascular medications; anyone taking prescription medications should consult a physician before using any Vitex-derived supplement.

### How does Vitexdoin F compare to other Vitex flavonoids in terms of antioxidant strength?

Vitexdoin F is one of the most potent flavonoids found in Vitex species, demonstrating superior free radical scavenging activity against DPPH and ABTS markers compared to ascorbic acid in laboratory studies. Its antioxidant potency correlates strongly with the total phenolic content of the plant fraction, meaning extracts with higher Vitexdoin F concentrations typically show greater antioxidant capacity. While Vitex extracts contain multiple complementary flavonoids, Vitexdoin F represents a key contributor to the overall antioxidant profile of the plant.

### What is the relationship between Vitexdoin F and the anti-inflammatory effects of Vitex supplements?

Vitexdoin F belongs to a class of flavonoids structurally related to compounds that are recognized for their anti-inflammatory potential within Vitex genus extracts. While Vitexdoin F itself is studied primarily for antioxidant mechanisms, the structural similarities between it and other anti-inflammatory Vitex flavonoids suggest complementary biological activity when present together in whole extracts. Research indicates that the combined effect of multiple Vitex flavonoids, including those related to Vitexdoin F, may contribute to the observed anti-inflammatory benefits in traditional use.

### Why might whole Vitex extracts containing Vitexdoin F be more effective than isolated forms?

Whole Vitex extracts provide a synergistic blend of flavonoids including Vitexdoin F alongside structurally related compounds that work together to enhance antioxidant and anti-inflammatory activity. Vitexdoin F's antioxidant potency is optimized when present within the context of the plant's complete phenolic profile, which may enhance bioavailability and biological function. Standardized extracts that preserve multiple Vitex flavonoids typically demonstrate stronger in vitro antioxidant activity compared to isolated single compounds.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*